Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CA, INC.
Report date November 05, 2018 · Filed November 05, 2018
Section 16 reporting ended · disclosed 2018-11-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.10 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-05 transaction · row 1
1 source rowRow 1 · 2018-11-05 · Disposition to issuer · Disposed 25,000 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger between the Issuer, Broadcom Inc., and Collie Acquisition Corp., dated as of July 11, 2018, in exchange for a cash payment of $44.50 per share without interest thereon (the "Merger Consideration"). |
| Deferred Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2018-11-05 | Direct | 0 |
Reported balance
After 2018-11-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-11-05 · Disposition to issuer · Disposed 135,534.806 · Balance 0 F2: Previously issued under the Issuer's Compensation Plans for Non-Employee Directors. F3: Disposed of pursuant to the Agreement and Plan of Merger between the Issuer, Broadcom Inc., and Collie Acquisition Corp., dated as of July 11, 2018, in exchange for a cash payment of $44.50 per share without interest thereon. F4: Deferred Stock Units are convertible into Common Stock on a one-for-one basis. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger between the Issuer, Broadcom Inc., and Collie Acquisition Corp., dated as of July 11, 2018, in exchange for a cash payment of $44.50 per share without interest thereon (the "Merger Consideration").
F2: Previously issued under the Issuer's Compensation Plans for Non-Employee Directors.
F3: Disposed of pursuant to the Agreement and Plan of Merger between the Issuer, Broadcom Inc., and Collie Acquisition Corp., dated as of July 11, 2018, in exchange for a cash payment of $44.50 per share without interest thereon.
F4: Deferred Stock Units are convertible into Common Stock on a one-for-one basis.
Merck & Co., Inc.
Report date November 03, 2009 · Filed November 04, 2009
Section 16 reporting ended · disclosed 2009-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 1
1 source rowRow 1 · 2009-11-03 · Disposition to issuer · Disposed 8,750 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. |
| Stock Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2009-11-03 · Disposition to issuer · Disposed 30,556.86 · Balance 0 F2: Each unit is the economic equivalent of one share of common stock. F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. |
| Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2009-11-03 · Disposition to issuer · Disposed 48,738.42 · Balance 0 F2: Each unit is the economic equivalent of one share of common stock. F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.
F2: Each unit is the economic equivalent of one share of common stock.
F3: Upon closing of the Merger, the cash value of the units became payable to the reporting person in accordance with the terms of the 2006 Directors Compensation Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 21, 2003 Filed Oct 23, 2003 13:26 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 125 | $16.00 Strike: $0.00 | $2,000.00 |
DisclosureSEC source: 0000310158-03-000090 · wei230.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,631.4 Underlying: Common Shares · 125 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| October 01, 2003 Filed Oct 2, 2003 16:42 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 615.14 | $15.85 Strike: $0.00 | $9,749.97 |
DisclosureSEC source: 0000310158-03-000085 · wei226.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,506.4 Underlying: Common Shares · 615.14 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| September 23, 2003 Filed Sep 24, 2003 22:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 183.48 | $16.35 Strike: $0.00 | $2,999.90 |
DisclosureSEC source: 0000310158-03-000079 · wei221.xml · derivative · entry 2 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,891.26 Underlying: Common Shares · 183.48 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: All figures in Column 9 include 136.05 shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of August 26, 2003. Read SEC document |
| September 22, 2003 Filed Sep 24, 2003 22:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 61.39 | $16.29 Strike: $0.00 | $1,000.04 |
DisclosureSEC source: 0000310158-03-000079 · wei221.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,707.78 Underlying: Common Shares · 61.39 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. Read SEC document |
| August 14, 2003 Filed Aug 15, 2003 21:40 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 62.27 | $16.06 Strike: $0.00 | $1,000.06 |
DisclosureSEC source: 0000310158-03-000064 · wei208.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,510.34 Underlying: Common Shares · 62.27 shares Expires not disclosed F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 30, 2003 Filed Aug 1, 2003 15:22 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 116.62 | $17.15 Strike: $0.00 | $2,000.03 |
DisclosureSEC source: 0000310158-03-000053 · wei182.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,448.07 Underlying: Common Shares · 116.62 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 22, 2003 Filed Jul 23, 2003 21:27 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 117.86 | $16.97 Strike: $0.00 | $2,000.08 |
DisclosureSEC source: 0000310158-03-000048 · wei160.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,331.45 Underlying: Common Shares · 117.86 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 16, 2003 Filed Jul 17, 2003 18:08 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 59.1 | $16.92 Strike: $0.00 | $999.97 |
DisclosureSEC source: 0000310158-03-000044 · wei126.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,213.59 Underlying: Common Shares · 59.1 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 10, 2003 Filed Jul 14, 2003 18:24 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 58.14 | $17.20 Strike: $0.00 | $1,000.01 |
DisclosureSEC source: 0000310158-03-000040 · wei116.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,154.49 Underlying: Common Shares · 58.14 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 02, 2003 Filed Jul 2, 2003 22:15 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 103.36 | $19.35 Strike: $0.00 | $2,000.02 |
DisclosureSEC source: 0000310158-03-000035 · wei97.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,096.35 Underlying: Common Shares · 103.36 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| July 01, 2003 Filed Jul 2, 2003 13:00 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 513.16 | $19.00 Strike: $0.00 | $9,750.04 |
DisclosureSEC source: 0000310158-03-000032 · wei94.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,992.99 Underlying: Common Shares · 513.16 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| June 24, 2003 Filed Jun 25, 2003 22:24 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 52.6 | $19.01 Strike: $0.00 | $999.93 |
DisclosureSEC source: 0000310158-03-000027 · wei78.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,479.83 Underlying: Common Shares · 52.6 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
| June 23, 2003 Filed Jun 25, 2003 19:20 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantStock Equivalent Units · Derivative | 209.64 | $19.08 Strike: $0.00 | $3,999.93 |
DisclosureSEC source: 0000310158-03-000022 · wei73.xml · derivative · entry 1 WEINBACH ARTHUR F · CIK 0001198853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,427.23 Underlying: Common Shares · 209.64 shares Expires 1988-08-08 F1 · derivative.exercise_price: 1 for 1 F2 · kind: The stock equivalent units were credited in a deferred account under the Directors Deferred Compensation Plan. F3 · derivative.exercise_date: Fictitious date inserted to facilitate filing of report. F4 · derivative.expiration_date: Fictitious date inserted to faciliate filing of report. The stock equivalent units are payable in cash following termination of the reporting person's service as a director of the Issuer. F5 · balance_after: Includes shares acquired pursuant to a dividend reinvestment feature of the Directors Deferred Compensation Plan and Directors Stock Equivalency Program, as of May 27, 2003. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.